SFS Group AG 2016 AR2
The report highlights SFS Group's successful 2016 financial year, achieving 5.9% organic growth in its core business and reaching record consolidated sales of CHF 1,437 million. The company significantly expanded its position in the medical device industry through the strategic acquisitions of Tegra Medical and Stamm. Profitability improved substantially, with the adjusted EBITA margin rising to 14.4%. Additionally, SFS Group advanced its sustainability reporting by conducting its first materiality assessment to identify key ESG topics in alignment with GRI G4 guidelines.
Company: SFS Group AG
Sector: Manufacturing
Country: Switzerland
Year: 2016
Type: AR2
Pages: 130
Back to company
SFS Group AG
Annual Report
The report highlights SFS Group's successful 2016 financial year, achieving 5.9% organic growth in its core business and reaching record consolidated sales of CHF 1,437 million. The company significantly expanded its position in the medical device industry through the strategic acquisitions of Tegra Medical and Stamm. Profitability improved substantially, with the adjusted EBITA margin rising to 14.4%. Additionally, SFS Group advanced its sustainability reporting by conducting its first materiality assessment to identify key ESG topics in alignment with GRI G4 guidelines.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees